about
ADDing a piece to the puzzle of cognition in schizophrenia.Criteria for symptom remission revisited: a study of patients affected by schizophrenia and schizoaffective disorders.Genomics and epigenomics in novel schizophrenia drug discovery: translating animal models to clinical research and back.Detecting syntactic and semantic anomalies in schizophrenia.Integrated cognitive remediation and standard rehabilitation therapy in patients of schizophrenia: persistence after 5years.Theory of Mind intervention for outpatients with schizophrenia.Cognitive dysfunction and glutamate reuptake: effect of EAAT2 polymorphism in schizophrenia.Self-awareness of cognitive functioning in schizophrenia: patients and their relatives.Combined social cognitive and neurocognitive rehabilitation strategies in schizophrenia: neuropsychological and psychopathological influences on Theory of Mind improvement.Combined neurocognitive and metacognitive rehabilitation in schizophrenia: Effects on bias against disconfirmatory evidence.COMT and 5-HT1A-receptor genotypes potentially affect executive functions improvement after cognitive remediation in schizophrenia.HTTLPR functional polymorphism in schizophrenia: executive functions vs. sustained attention dissociation.Theory of mind and emotion processing training for patients with schizophrenia: preliminary findings.Catechol-O-methyltransferase (COMT) genotype biases neural correlates of empathy and perceived personal distress in schizophrenia.Cognitive remediation and functional improvement in schizophrenia: Is it a matter of size?The communicative impairment as a core feature of schizophrenia: Frequency of pragmatic deficit, cognitive substrates, and relation with quality of life.Achieving recovery in patients with schizophrenia through psychosocial interventions: A retrospective study.Influence of catechol-O-methyltransferase Val158Met polymorphism on neuropsychological and functional outcomes of classical rehabilitation and cognitive remediation in schizophrenia.Functional and structural brain correlates of theory of mind and empathy deficits in schizophrenia.Effect of glutamate transporter EAAT2 gene variants and gray matter deficits on working memory in schizophrenia.Consensus five factor PANSS for evaluation of clinical remission: effects on functioning and cognitive performances.Visual and audio emotion processing training for outpatients with schizophrenia: an integrated multisensory approach.Effect of 5-HT1A-receptor functional polymorphism on Theory of Mind performances in schizophrenia.Computer-aided neurocognitive remediation in schizophrenia: durability of rehabilitation outcomes in a follow-up study.Patterns of evidence integration in schizophrenia and delusion.'Theory' of mind impairment in patients affected by schizophrenia and in their parents.COMT Val158Met and 5-HT1A-R -1019 C/G polymorphisms: effects on the negative symptom response to clozapine.P.3.12 Association study of GSK-3β −50T/C polymorphism with executive performances in schizophreniaP.3.10 Association study of GSK-3β −50T/C polymorphism with haloperidol resistance in schizophreniaSaitohin polymorphism and executive dysfunction in schizophreniaExploring anxiety in schizophrenia: New light on a hidden figureCOMT and STH polymorphisms interaction on cognition in schizophreniaExploring effects of EAAT polymorphisms on cognitive functions in schizophreniaFactors affecting cognitive remediation response in schizophrenia: The role of COMT gene and antipsychotic treatmentResearch Highlights: Highlights from the latest articles on the pharmacogenomics of neuropsychiatric disorders
P50
Q33362225-EEB9B435-E7FE-446F-B59C-53530F6B676DQ35057412-43C912F1-C1CD-406E-A920-1C9619FB2A48Q38262765-8A3DEEF1-BF28-4453-8C9B-6D97C32643E9Q38401070-3B47A319-3552-4E5C-B68B-A90FDE22DF77Q38763029-6DEC1968-FF41-414B-9C0F-5B7E4579EE9AQ39473207-06553645-96AA-4881-B778-95D31582D569Q39597592-8712D6BA-4A5A-4E40-8FF7-39A8AD74F0F7Q39642598-8342DA04-8378-45C9-B9CD-DB6C11383B4CQ40848645-DCC11544-17A0-416C-BC5D-AFB741BD4D6EQ41252012-BF071E3B-1EEF-458B-B0F2-1A917A5E47C7Q43170052-5AFD7315-6B5E-453B-B440-E6BED6D504F5Q43264185-F47FA88B-AA3E-456A-BDF4-7C56730747ABQ43536563-A0CC2854-BE63-4254-8A30-E07D2CF32D1EQ46008497-67D623C1-B2BA-4BF9-9B6B-11416FD259CFQ47258614-C048F72B-D338-476B-8EBC-687044DCC17AQ47637590-C6414B78-4EA6-4754-989F-14F07F2C58F1Q47688150-2187915E-522F-48C2-803E-9898F12E08EAQ48229216-54D29C20-C20B-4A86-8B9F-321B1D531D56Q48505279-129608D9-CCA5-46BA-9C0A-8E033F8B7A91Q48969583-CC0BAA4C-0B56-4544-BF15-116398A575E4Q49590987-4D7ECB61-08D3-438F-9019-45A3B8476DE5Q50140183-1E79B77C-E85A-4662-B99D-631BBA9D3EF3Q51025369-7C1DCA4D-F74B-490B-B730-558ACF0C7C03Q51043326-BB6720C0-1153-46F2-BD27-1AF432BB5A8AQ51784286-A793D41D-D0A2-45C3-B776-19DD890736E3Q51862340-DD0428AB-29DB-493C-A341-0DFD5310CB1CQ53652604-A44D4186-1EAA-49E8-B1C9-45D741D2BFECQ60631042-7C44737C-DCF7-45BE-8C27-C848E93966A9Q60631045-CA8E9E0B-71D6-444F-A3E4-A10623B353FBQ60646942-DAED6A50-DED9-49E2-B42E-692472A581DDQ61443142-71A0BE71-F80E-478A-BB5C-24F2F8AABAFDQ61443152-262D2B92-BB15-4C64-BC8D-33C5001B74BCQ61443188-7245AC34-9F45-4D0B-9746-35AD9DB6237CQ61443190-7D2692EE-07E4-4CD7-A663-425F134BA0F5Q61443196-B77F8383-34DE-47C5-A334-7BEA6C56033A
P50
description
hulumtuese
@sq
researcher
@en
ricercatrice
@it
wetenschapper
@nl
հետազոտող
@hy
name
Marta Bosia
@ast
Marta Bosia
@en
Marta Bosia
@es
Marta Bosia
@nl
Marta Bosia
@sl
type
label
Marta Bosia
@ast
Marta Bosia
@en
Marta Bosia
@es
Marta Bosia
@nl
Marta Bosia
@sl
prefLabel
Marta Bosia
@ast
Marta Bosia
@en
Marta Bosia
@es
Marta Bosia
@nl
Marta Bosia
@sl
P1053
K-5388-2016
P106
P1153
16229352900
P21
P214
23144928028454340467
P31
P3829
P396
IT\ICCU\BVEV\211440
P496
0000-0002-9658-2759
P735
P7859
viaf-23144928028454340467